The Lancet

New Business

China’s Akeso, dubbed biotech’s DeepSeek, gets share boost on cancer-drug trial data

Shares of Chinese drug firm Akeso – likened by some Western media outlets to artificial intelligence start-up DeepSeek – rose…

Read More »
New Business

Chinese biotech firm Akeso tumbles on US partner Summit’s setback for cancer drug

Chinese biotech firm Akeso, whose cancer drug has been hailed as a breakthrough for the nation’s pharmaceutical industry, suffered a…

Read More »
Tech

Lancet Psychiatry Study Uncovers the Risks of Discontinuation Symptoms

Research indicates that 15% of patients discontinuing antidepressants suffer from withdrawal symptoms, with 3% experiencing severe effects. This contrasts with…

Read More »
Back to top button